Neoadjuvant SHR-1701 with or without chemotherapy in unresectable stage III non-small-cell lung cancer: A proof-of-concept, phase 2 trial

Authors:

Top Cited Papers
Open Access
Abstract
No abstract available
Funding Information
  • Jiangsu Hengrui Pharmaceuticals Co Ltd

This publication has 46 references indexed in Scilit: